We are an International Consulting Company devoted to the Pharma business, mainly in the field of Biotechnology. Consutrade partners are professionals with wide know-how and long experience in Biotech industry and business, up to 30 years in the area. Our daily work consists in finding companies of all over the world with something to offer. Usually we find small companies or development groups with limited resources which have developed promising products or technologies. We have a number of mAbs with serious potential to become new drugs in the field of Oncology. The companies we represent are open to several formulas of collaboration, from co-development to direct acquisition, including any intermediate stage. Our represented drugs are in advanced step of pre-clinical development and can prove relevant results for their intended targets.
We offer In-Licensing and/or Collaboration Projects for innovative mAbs in oncology field.Our mAbs are directed against:
- -Endosialin (CD248)
- -several bispecific antibodies
If you have question about this subject or want to know more about one or more of our molecules, please don’t hesitate to contact us.